At Myka Labs, our mission is to help millions of patients with pancreatic cancer and other challenging conditions live longer, healthier lives.  Our Conflux(TM) platform combines advanced artificial intelligence and computer vision algorithms with miniaturized ultrasound sensors to map the internal anatomy around a patient’s malignancy—in real time and with exquisite accuracy.  With the benefit of Conflux’s sophisticated mapping capabilities, care teams are enabled to carry out treatments less invasively, with potentially enormous benefits for patients.  Myka Labs is a clinical-stage company backed by leading biopharma/medtech VC firm Mission BioCapital.

Myka Labs, Inc.

Org chart

Teams

Offices